BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu XN, Zhang CY, Jin XD, Li YZ, Zheng XZ, Li L. Inhibitory effect of schisandrin B on gastric cancer cells in vitroWorld J Gastroenterol 2007; 13(48): 6506-6511 [PMID: 18161920 DOI: 10.3748/wjg.v13.i48.6506]
URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6506.htm
Number Citing Articles
1
Xiaohui Yang, Shuai Wang, Yunchuan Mu, Yixiong Zheng. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cellsOncology Reports 2016; 36(4): 1799 doi: 10.3892/or.2016.4992
2
I. Slaninová, L. Březinová, L. Koubíková, J. Slanina. Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells – Study of structure–activity relationshipToxicology in Vitro 2009; 23(6): 1047 doi: 10.1016/j.tiv.2009.06.008
3
Bing Wang, Xiaowei Wang, Xing Tong, Yingang Zhang. Schisandrin B Inhibits Cell Viability and Migration, and Induces Cell Apoptosis by circ_0009112/miR-708-5p Axis Through PI3K/AKT Pathway in OsteosarcomaFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.588670
4
Sabesan Yoganathan, Anushan Alagaratnam, Nikita Acharekar, Jing Kong. Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in CancerCells 2021; 10(2): 458 doi: 10.3390/cells10020458
5
Qian Xu, Wen Cheng, Jinrui Wei, Yan Ou, Xian Xiao, Yingjie Jia. Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironmentDiscover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00798-w
6
Joanna Japhet Tibenda, Yuhua Du, Yi Nan, Shicong Huang, Guoqing Chen, Na Ning, Xia Li, Yi Yang, Ling Yuan. Astragalus Mongholicus: A review of its pharmacological mechanisms against gastric cancerJournal of Herbal Medicine 2024; : 100881 doi: 10.1016/j.hermed.2024.100881
7
Xuanxuan Dai, Changtian Yin, Guilong Guo, Yi Zhang, Chenguang Zhao, Jianchang Qian, Ouchen Wang, Xiaohua Zhang, Guang Liang. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3Toxicology and Applied Pharmacology 2018; 358: 110 doi: 10.1016/j.taap.2018.09.005
8
Qiuli Ding, Xiaoyan Li, Yongcun Sun, Xinru Zhang. RETRACTED: Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-429Cancer Biomarkers 2019; 24(4): 497 doi: 10.3233/CBM-182222
9
Yan Jiang, Qiuli Zhang, Jinsuo Bao, Chenghua Du, Jian Wang, Qiang Tong, Chang Liu. Schisandrin B inhibits the proliferation and invasion of glioma cells by regulating the HOTAIR–micoRNA-125a–mTOR pathwayNeuroReport 2017; 28(2): 93 doi: 10.1097/WNR.0000000000000717
10
Vanessa Anna Co, Hani El-Nezami, Yawen Liu, Bonsra Twum, Priyanka Dey, Paul A. Cox, Shalu Joseph, Roland Agbodjan-Dossou, Mehdi Sabzichi, Roger Draheim, Murphy Lam Yim Wan. Schisandrin B Suppresses Colon Cancer Growth by Inducing Cell Cycle Arrest and Apoptosis: Molecular Mechanism and Therapeutic PotentialACS Pharmacology & Translational Science 2024; 7(3): 863 doi: 10.1021/acsptsci.4c00009
11
Asmaa O. Sana‐Eldine, Hanan M. Abdelgawad, Nahla S. Kotb, Nagwa I. Shehata. The potential effect of Schisandrin‐B combination with panitumumab in wild‐type and mutant colorectal cancer cell lines: Role of apoptosis and autophagyJournal of Biochemical and Molecular Toxicology 2023; 37(5) doi: 10.1002/jbt.23324
12
Zeyu Ma, Gang Xu, Yingying Shen, Shufang Hu, Xia Lin, Jun Zhou, Wei Zhao, Jian Liu, Jiaoli Wang, Jufeng Guo. Schisandrin B-mediated TH17 cell differentiation attenuates bowel inflammationPharmacological Research 2021; 166: 105459 doi: 10.1016/j.phrs.2021.105459
13
Jufeng Guo, Yingying Shen, Xia Lin, Honggang Chen, Jian Liu. Schisandrin B promotes TH1 cell differentiation by targeting STAT1International Immunopharmacology 2021; 101: 108213 doi: 10.1016/j.intimp.2021.108213
14
Bosu Meng, Shouhong Gao, Jihui Chen, Bin Wang, Yuhui Mu, Yan Liu, Zhipeng Wang, Wansheng Chen, Idaira Pacheco-Fernández. A LC-MS/MS Method for Quantifying the Schisandrin B and Exploring Its Intracellular Exposure Correlating Antitumor EffectJournal of Analytical Methods in Chemistry 2023; 2023: 1 doi: 10.1155/2023/8898426
15
Liping Chen, Chunrong He, Min Zhou, Jiaying Long, Ling Li. Research Progress on the Mechanisms of Polysaccharides against Gastric CancerMolecules 2022; 27(18): 5828 doi: 10.3390/molecules27185828
16
Ruyue Fan, Xiurui Han, Di Xiao, Lihua He, Yanan Gong, Lu Sun, Dongjie Fan, Yuanhai You, Tong Wang, Xiaomei Yan, Maojun Zhang, Jianzhong Zhang. Identification of Functional Interactome of Gastric Cancer Cells with Helicobacter pylori Outer Membrane Protein HpaA by HPLC-MS/MSBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1052926
17
Ya-Jing Li, Hong-Tao Liu, Chao-Jun Xue, Xiao-Qin Xing, Song-Tao Dong, Lin-Shan Wang, Cong-Yang Ding, Lu Meng, Zhan-Jun Dong. The synergistic anti-tumor effect of schisandrin B and apatinibJournal of Asian Natural Products Research 2020; 22(9): 839 doi: 10.1080/10286020.2019.1645131
18
TIANZHU LI, YU ZHANG, TONG ZHANG, YANNAN LI, HUI XUE, JINGLONG CAO, WENSHUANG HOU, YINGHUA LUO, CHENGHAO JIN. Schisandrin B exerts anticancer effects on human gastric cancer cells through ROS-mediated MAPK, STAT3, and NF-κB pathwaysBIOCELL 2023; 47(1): 195 doi: 10.32604/biocell.2023.025593
19
Zhiman Li, Lijuan Zhao, Yunshi Xia, Jianbo Chen, Mei Hua, Yinshi Sun. Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver FibrosisMolecules 2021; 26(22): 6882 doi: 10.3390/molecules26226882
20
María Rubín-García, Facundo Vitelli-Storelli, Antonio José Molina, Raúl Zamora-Ros, Nuria Aragonés, Eva Adarnaz, Gemma Castaño-Vinyals, Mireia Obón-Santacana, Inés Gómez-Acebo, Ana Molina-Barceló, Guillermo Fernández-Tardón, José J Jiménez-Moleón, Juan Alguacil, María Dolores Chirlaque, Estefanía Toledo, Beatriz Pérez-Gómez, Marina Pollán, Manolis Kogevinas, Vicente Martín. Association between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-SpainNutrients 2020; 12(11): 3281 doi: 10.3390/nu12113281
21
Chun-Ming Chang, Ting-Ruei Liang, Ho Yin Pekkle Lam. The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β ProductionBiomolecules 2024; 14(1): 74 doi: 10.3390/biom14010074